Cargando…

A Preliminary Study for an Intraoperative 3D Bioprinting Treatment of Severe Burn Injuries

Intraoperative three-dimensional fabrication of living tissues could be the next biomedical revolution in patient treatment. APPROACH: We developed a surgery-ready robotic three-dimensional bioprinter and demonstrated that a bioprinting procedure using medical grade hydrogel could be performed using...

Descripción completa

Detalles Bibliográficos
Autores principales: Albouy, Marion, Desanlis, Adeline, Brosset, Sophie, Auxenfans, Celine, Courtial, Edwin-Joffrey, Eli, Kyle, Cambron, Scott, Palmer, Justin, Vidal, Luciano, Thépot, Amélie, Dos Santos, Morgan, Marquette, Christophe A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849420/
https://www.ncbi.nlm.nih.gov/pubmed/35186622
http://dx.doi.org/10.1097/GOX.0000000000004056
Descripción
Sumario:Intraoperative three-dimensional fabrication of living tissues could be the next biomedical revolution in patient treatment. APPROACH: We developed a surgery-ready robotic three-dimensional bioprinter and demonstrated that a bioprinting procedure using medical grade hydrogel could be performed using a 6-axis robotic arm in vivo for treating burn injuries. RESULTS: We conducted a pilot swine animal study on a deep third-degree severe burn model. We observed that the use of cell-laden bioink as treatment substantially affects skin regeneration, producing in situ fibroblast growth factor and vascular endothelial growth factor, necessary for tissue regeneration and re-epidermalization of the wound. CONCLUSIONS: We described an animal study of intraoperative three-dimensional bioprinting living tissue. This emerging technology brings the first proof of in vivo skin printing feasibility using a surgery-ready robotic arm-based bioprinter. Our positive outcome in skin regeneration, joined with this procedure’s feasibility, allow us to envision the possibility of using this innovative approach in a human clinical trial in the near future.